![Charles Berkman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Berkman
Director/Board Member at
PFENEX INC.
Net worth: 554 728 $ as of 2026-04-29
Profile
Charles Stuart Berkman currently works at Ligand UK Research Ltd., as Secretary & Director, Pelican, Inc., as Secretary, Director, Senior VP & General Counsel from 2020, Ligand UK Group Ltd., as Secretary & Director, Metabasis Therapeutics, Inc., as Secretary & Vice President from 2010, OmniAb Operations, Inc., as Secretary & Chief Legal Officer from 2022, and OmniAb, Inc., as Secretary & Chief Legal Officer from 2022.
Mr. Berkman also formerly worked at Ligand UK Ltd., as Secretary & Director from 2019 to 2022, Ligand Pharmaceuticals, Inc., as Secretary, Senior Vice President & General Counsel from 2018 to 2022, Baker & McKenzie LLP (Illinois), as Attorney from 2000 to 2001, and Lyon & Lyon, Inc., as Attorney from 1993 to 2000.
Mr. Berkman received his undergraduate degree from The University of Texas at Austin and graduate degree from The University of Texas School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMNIAB, INC. 0.28% | 2026-04-22 | 399,085 ( 0.28% ) | 554 728 $ | 2026-04-29 |
Charles Berkman active positions
| Companies | Position | Start |
|---|---|---|
| PFENEX INC. | Director/Board Member | 2020-09-30 |
| OMNIAB, INC. | General Counsel | 2022-02-28 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Corporate Secretary | 2010-01-28 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2018-10-11 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | General Counsel | 2022-02-28 |
Former positions of Charles Berkman
| Companies | Position | End |
|---|---|---|
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | 2024-03-18 |
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 2022-10-31 |
| VERNALIS | Director/Board Member | 2022-10-31 |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 2001-10-31 |
| ░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Charles Berkman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
The University of Texas School of Law
 The University of Texas School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
- Stock Market
- Insiders
- Charles Berkman
